Phillip D. Kronstein from CDER’s Good Clinical Practice Assessment Branch provides a case study when a sponsor submitted an NDA for a new molecular entity. The drug was the first targeted treatment for a serious disorder and the OND review division requested data audit inspections of the sponsor, CRO, and several clinical investigators.
For more data integrity case studies, visit www.fda.gov/dr...
_______________________________
FDA CDER’s Small Business and Industry Assistance (SBIA) educates and provides assistance in understanding the regulatory aspects of human drug products & clinical research.
Upcoming training and free continuing education credits: www.fda.gov/cd...
CDER SBIA 2018 Playlist: • 2018 CDER Small Busine...
LinkedIn: / cder-small-business-an...
Training resources: www.fda.gov/cd...
Twitter: / fda_drug_info
CDER small business e-mail update subscription: updates.fda.go...
Email: CDERSBIA@fda.hhs.gov
Phone: (301) 796-6707 I (866) 405-5367
Негізгі бет A Case Example of the Review of Audit Trails in GCP Inspections (11of11) GCP Data Integrity Workshop
Пікірлер